378 related articles for article (PubMed ID: 25425966)
1. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
[TBL] [Abstract][Full Text] [Related]
2. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
[TBL] [Abstract][Full Text] [Related]
3. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
[TBL] [Abstract][Full Text] [Related]
4. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
Peng L; Bian XW; Li DK; Xu C; Wang GM; Xia QY; Xiong Q
Sci Rep; 2015 Aug; 5():13413. PubMed ID: 26292924
[TBL] [Abstract][Full Text] [Related]
5. Identification of tissue-specific tumor biomarker using different optimization algorithms.
Bhowmick SS; Bhattacharjee D; Rato L
Genes Genomics; 2019 Apr; 41(4):431-443. PubMed ID: 30535858
[TBL] [Abstract][Full Text] [Related]
6. A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data.
Raman P; Zimmerman S; Rathi KS; de Torrenté L; Sarmady M; Wu C; Leipzig J; Taylor DM; Tozeren A; Mar JC
Cancer Genet; 2019 Jun; 235-236():1-12. PubMed ID: 31296308
[TBL] [Abstract][Full Text] [Related]
7. A novel model used to detect differential splice junctions as biomarkers in prostate cancer from RNA-Seq data.
Rezaeian I; Tavakoli A; Cavallo-Medved D; Porter LA; Rueda L
J Biomed Inform; 2016 Apr; 60():422-30. PubMed ID: 26992567
[TBL] [Abstract][Full Text] [Related]
8. Efficient identification of miRNAs for classification of tumor origin.
Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
[TBL] [Abstract][Full Text] [Related]
9. An integrated tool for determining the primary origin site of metastatic tumours.
Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
[TBL] [Abstract][Full Text] [Related]
10. A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq.
Sundaramurthy G; Eghbalnia HR
Comput Biol Med; 2015 Dec; 67():29-40. PubMed ID: 26492320
[TBL] [Abstract][Full Text] [Related]
11. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.
Guan Q; Yan H; Chen Y; Zheng B; Cai H; He J; Song K; Guo Y; Ao L; Liu H; Zhao W; Wang X; Guo Z
BMC Genomics; 2018 Jan; 19(1):99. PubMed ID: 29378509
[TBL] [Abstract][Full Text] [Related]
12. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
Staub E; Buhr HJ; Gröne J
Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers.
Kaczkowski B; Tanaka Y; Kawaji H; Sandelin A; Andersson R; Itoh M; Lassmann T; Hayashizaki Y; Carninci P; Forrest AR;
Cancer Res; 2016 Jan; 76(2):216-26. PubMed ID: 26552699
[TBL] [Abstract][Full Text] [Related]
14. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA.
Paul MR; Levitt NP; Moore DE; Watson PM; Wilson RC; Denlinger CE; Watson DK; Anderson PE
BMC Genomics; 2016 Mar; 17():263. PubMed ID: 27029813
[TBL] [Abstract][Full Text] [Related]
15. A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.
Jiang W; Shen Y; Ding Y; Ye C; Zheng Y; Zhao P; Liu L; Tong Z; Zhou L; Sun S; Zhang X; Teng L; Timko MP; Fan L; Fang W
Int J Cancer; 2018 Jan; 142(2):357-368. PubMed ID: 28921531
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.
Xu Q; Chen J; Ni S; Tan C; Xu M; Dong L; Yuan L; Wang Q; Du X
Mod Pathol; 2016 Jun; 29(6):546-56. PubMed ID: 26990976
[TBL] [Abstract][Full Text] [Related]
17. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
Li P; Conley A; Zhang H; Kim HL
BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
[TBL] [Abstract][Full Text] [Related]
18. Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm.
Martinez-Ledesma E; Verhaak RG; Treviño V
Sci Rep; 2015 Jul; 5():11966. PubMed ID: 26202601
[TBL] [Abstract][Full Text] [Related]
19. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.
Rosenwald S; Gilad S; Benjamin S; Lebanony D; Dromi N; Faerman A; Benjamin H; Tamir R; Ezagouri M; Goren E; Barshack I; Nass D; Tobar A; Feinmesser M; Rosenfeld N; Leizerman I; Ashkenazi K; Spector Y; Chajut A; Aharonov R
Mod Pathol; 2010 Jun; 23(6):814-23. PubMed ID: 20348879
[TBL] [Abstract][Full Text] [Related]
20. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing.
Cieslik M; Chugh R; Wu YM; Wu M; Brennan C; Lonigro R; Su F; Wang R; Siddiqui J; Mehra R; Cao X; Lucas D; Chinnaiyan AM; Robinson D
Genome Res; 2015 Sep; 25(9):1372-81. PubMed ID: 26253700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
